Biotechnology Value Fund L P's Form 4 filing
POINT Biopharma Global Inc. (PNT) · filed Dec 20, 2023
- Accession no.
- 0001193805-23-001635
- Filed
- Dec 20, 2023, 6:09 PM ET
- Trade date
- Dec 18, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $213.7M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | Other: Former 10% Owner |
| BVF Partners L PCIK 0001055947 | Other: Former 10% Owner |
| BVF IncCIK 0001056807 | Other: Former 10% Owner |
| Biotechnology Value Fund II LPCIK 0001102444 | Other: Former 10% Owner |
| Lampert Mark NCIK 0001233840 | Other: Former 10% Owner |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Other: Former 10% Owner |
| BVF Partners OS Ltd.CIK 0001660684 | Other: Former 10% Owner |
| BVF I GP LLCCIK 0001803805 | Other: Former 10% Owner |
| BVF II GP LLCCIK 0001803806 | Other: Former 10% Owner |
| BVF GP Holdings LLCCIK 0001803809 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2023 | Common Stock, $0.0001 par value | SSaleDisposed | −8,974,245 | $12.45 | −$111,729,350.25 | 0 | Direct | |
| Dec 18, 2023 | Common Stock, $0.0001 par value | SSaleDisposed | −7,290,667 | $12.45 | −$90,768,804.15 | 0 | Direct | |
| Dec 18, 2023 | Common Stock, $0.0001 par value | SSaleDisposed | −896,366 | $12.45 | −$11,159,756.7 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.